Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05278975
What this trial is testing

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Who this might be right for
Malignant Pleural EffusionMalignant Pleural MesotheliomaMesothelioma+3 more
RS Oncology LLC 50
Early research (Phase 1)Study completedNCT03237390
What this trial is testing

Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
Mayo Clinic 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650986
What this trial is testing

Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Melanoma+47 more
Roswell Park Cancer Institute 15
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT03808870
What this trial is testing

A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced Cancer

Who this might be right for
Malignant Neoplasm
NatureWise Biotech & Medicals Corporation 21
Early research (Phase 1)Looking for participantsNCT06759649
What this trial is testing

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

Who this might be right for
NeoplasmCancer, Malignant Tumors
Compugen Ltd 200
Testing effectiveness (Phase 2)Study completedNCT00496353
What this trial is testing

MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED)

Who this might be right for
Neoplasm
Merck Sharp & Dohme LLC 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07389239
What this trial is testing

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

Who this might be right for
Ovarian CancerAdvanced Malignant Solid Tumor
University of Chicago 24
Early research (Phase 1)Study completedNCT02071537
What this trial is testing

Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors

Who this might be right for
Malignant NeoplasmSolid Tumors
University of Cincinnati 24
Early research (Phase 1)Active Not RecruitingNCT01303341
What this trial is testing

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent MelanomaRefractory Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Looking for participantsNCT06385925
What this trial is testing

TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Who this might be right for
Malignant Neoplasm
Tyligand Pharmaceuticals (Suzhou) Limited 440
Early research (Phase 1)WithdrawnNCT03359733
What this trial is testing

Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor

Who this might be right for
Lymphoma, MalignantAdvanced Solid Neoplasms
Calithera Biosciences, Inc
Early research (Phase 1)Ended earlyNCT00257881
What this trial is testing

Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Neoplasms
Wyeth is now a wholly owned subsidiary of Pfizer 46
Early research (Phase 1)Ended earlyNCT06546553
What this trial is testing

Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

Who this might be right for
NeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+3 more
Pfizer 10
Testing effectiveness (Phase 2)Study completedNCT01618136
What this trial is testing

An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors

Who this might be right for
Malignant Solid TumourOvarian CancerTriple Negative Breast Cancer+2 more
Eisai Limited 41
Testing effectiveness (Phase 2)Looking for participantsNCT04145622
What this trial is testing

Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

Who this might be right for
Advanced Solid TumorMalignant Solid Tumor
Daiichi Sankyo 250
Early research (Phase 1)Study completedNCT01822522
What this trial is testing

Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus

Who this might be right for
Advanced Malignant Solid NeoplasmHIV InfectionMetastatic Malignant Solid Neoplasm+2 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07797426
What this trial is testing

RT023 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumours
Shanghai Ruotuo Biosciences Co., Ltd. 318
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07077252
What this trial is testing

Phase I/II Study of SCTB39G in Advanced Solid Tumours

Who this might be right for
Advanced Malignant Solid Tumor
Sinocelltech Ltd. 30
Next Page